A Field Trial to examine the effect of hydroxychloroquine prophylaxis in preventing the sever forms of COVID-19 infection in asymptomatic healthcare workers (A double blind placebo controlled study)

Islamic Azad University0 个研究点目标入组 400 人开始时间: 待定最近更新: 2021年2月22日

试验速览

暂无简介。

•Healthcare workers and students of Islamic Azad University Tehran Medical Branch(IAUTMU) affiliated hospitals.
•Age 18-70 years
•No symptoms of COVID19 at the time of registration
•No history of COVID-19 diagnosis within the past 3 months from joining the study
•Desire to participate in the study and filling out the consent form

•Any of COVID-19 symptoms at registration: fever, chills, cough, dyspnea,runny nose, loss of smell, loss of taste, headache, sore throat, chest pain, abdominal pain, nausea, vomiting, diarrhea, malaise and musculoskeletal pain
•History of COVID-19 within the past 3 months
•Contraindications for hydroxychloroquine including allergy to hydroxychloroquine , G6PD, Long QT Syndrome, porphyria, retinopathy
•Sever kidney or liver disease
•Systemic lupus erythematosus, rheumatoid arthritis
•active cancer

发起方